Navigation überspringen
Universitätsbibliothek Heidelberg
Status: Bibliographieeintrag

Verfügbarkeit
Standort: ---
Exemplare: ---
heiBIB
 Online-Ressource
Verfasst von:Silva, Daniela [VerfasserIn]   i
 Chrobok, Michael [VerfasserIn]   i
 Rovesti, Giulia [VerfasserIn]   i
 Healy, Katie [VerfasserIn]   i
 Wagner, Arnika Kathleen [VerfasserIn]   i
 Maravelia, Panagiota [VerfasserIn]   i
 Gatto, Francesca [VerfasserIn]   i
 Mazza, Massimiliano [VerfasserIn]   i
 Mazzotti, Lucia [VerfasserIn]   i
 Lohmann, Volker [VerfasserIn]   i
 Sällberg Chen, Margaret [VerfasserIn]   i
 Sällberg, Matti [VerfasserIn]   i
 Buggert, Marcus [VerfasserIn]   i
 Pasetto, Anna [VerfasserIn]   i
Titel:Process development for adoptive cell therapy in academia
Titelzusatz:a pipeline for clinical-scale manufacturing of multiple TCR-T cell products
Verf.angabe:Daniela Nascimento Silva, Michael Chrobok, Giulia Rovesti, Katie Healy, Arnika Kathleen Wagner, Panagiota Maravelia, Francesca Gatto, Massimiliano Mazza, Lucia Mazzotti, Volker Lohmann, Margaret Sällberg Chen, Matti Sällberg, Marcus Buggert and Anna Pasetto
E-Jahr:2022
Jahr:16 June 2022
Umfang:16 S.
Fussnoten:Gesehen am 29.07.2022
Titel Quelle:Enthalten in: Frontiers in immunology
Ort Quelle:Lausanne : Frontiers Media, 2010
Jahr Quelle:2022
Band/Heft Quelle:13(2022), Artikel-ID 896242, Seite 1-16
ISSN Quelle:1664-3224
Abstract:Cellular immunotherapies based on T cell receptor (TCR) transfer are promising approaches for the treatment of cancer and chronic viral infections. The discovery of novel receptors is expanding considerably; however, the clinical development of TCR-T cell therapies still lags. Here we provide a pipeline for process development and clinical-scale manufacturing of TCR-T cells in academia. We utilized two TCRs specific for hepatitis C virus (HCV) as models because of their marked differences in avidity and functional profile in TCR-redirected cells. With our clinical-scale pipeline, we reproduced the functional profile associated with each TCR. Moreover, the two TCR-T cell products demonstrated similar yield, purity, transduction efficiency as well as phenotype. The TCR-T cell products had a highly reproducible yield of over 1.4 × 109 cells, with an average viability of 93%; 97.8-99% of cells were CD3+, of which 47.66 ± 2.02% were CD8+ T cells; the phenotype was markedly associated with central memory (CD62L+CD45RO+) for CD4+ (93.70 ± 5.23%) and CD8+ (94.26 ± 4.04%). The functional assessments in 2D and 3D cell culture assays showed that TCR-T cells mounted a polyfunctional response to the cognate HCV peptide target in tumor cell lines, including killing. Collectively, we report a solid strategy for the efficient large-scale manufacturing of TCR-T cells.
DOI:doi:10.3389/fimmu.2022.896242
URL:Bitte beachten Sie: Dies ist ein Bibliographieeintrag. Ein Volltextzugriff für Mitglieder der Universität besteht hier nur, falls für die entsprechende Zeitschrift/den entsprechenden Sammelband ein Abonnement besteht oder es sich um einen OpenAccess-Titel handelt.

kostenfrei: Volltext: https://doi.org/10.3389/fimmu.2022.896242
 kostenfrei: Volltext: https://www.frontiersin.org/articles/10.3389/fimmu.2022.896242
 DOI: https://doi.org/10.3389/fimmu.2022.896242
Datenträger:Online-Ressource
Sprache:eng
K10plus-PPN:1811985890
Verknüpfungen:→ Zeitschrift

Permanenter Link auf diesen Titel (bookmarkfähig):  https://katalog.ub.uni-heidelberg.de/titel/68948211   QR-Code
zum Seitenanfang